Profile for Agenus Inc. (AGEN)

$ 2.94   -0.10 (-3.29%) Volume: 2.6m 4:00 PM EDT 26-Jun-2019
After Hours:  $ 2.92   -0.02 (-0.68%) Volume: 11.42k 5:51 PM EDT 26-Jun-2019
Business Description:
Agenus Inc along with its subsidiaries is a pharmaceutical company. It is engaged in discovery and development of revolutionary new treatments that engage the body's immune system to benefit patients suffering from cancer.
Address: 3 Forbes Road, Lexington, MA, USA, 02421-7305
Telephone: +1 781 674-4400 Website: http://www.agenusbio.com
Facsimile: +1 781 674-4200 Email: [email protected]
Details
CEO: Garo H Armen
Employees: 294 Market Cap: 394.72m
Issue Type: CS
Auditor: KPMG LLP
Last Audit: Unqualified Opinion with Explanation
Indices: Biotechnology
Industry Classifications
Sector: Healthcare CIK: 1098972
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Biological Product (except Diagnostic) Manufacturing (325414)
SIC: Biological Products, Except Diagnostic Substances (2836)